Active, not recruitingPhase 2NCT01815359

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

Studying Epithelial tumor of the appendix

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Memorial Sloan Kettering Cancer Center
Principal Investigator
Garrett Nash, MD, MPH
Memorial Sloan Kettering Cancer Center
Intervention
Cytoreductive Surgery(procedure)
Enrollment
292 enrolled
Eligibility
18 years · All sexes
Timeline
2013 – 2026

Study locations (9)

Collaborators

The Cleveland Clinic · Brigham and Women's Hospital · University of Miami · University of Pittsburgh Medical Center · Washington University School of Medicine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01815359 on ClinicalTrials.gov

Other trials for Epithelial tumor of the appendix

Additional recruiting or active studies for the same condition.

See all trials for Epithelial tumor of the appendix →

← Back to all trials